e4life Devices Take Stage at Japan Health in Osaka from 25 th to 27 th June

Business Wire

6 hours ago

ROME--(BUSINESS WIRE)--Can electromagnetic waves neutralize respiratory viruses? The answer is yes: on the stage of the Japan Health fair, from 25 th to 27 th June, e4life, the Italian company active in the biodefense industry, will be among the leading players presenting its innovative devices which use electromagnetic waves to render harmless respiratory viruses present in the air (transported via bioaerosol).
Vincenzo Pompa, e4life CEO: 'e4life marks a breakthrough for applications in high-risk environments, both human and animal, to minimize contagion among the animals themselves and also to reduce the risk of spillover".
Share
This solution is a world first, with efficacy of over 90% and an almost instantaneous sanitizing action. Since it is 100% harmless to humans and animals, it does not require the evacuation of spaces and environments.
This Italian patent does not use chemical agents or filter materials, and is based on the transmission of microwaves which, at a specific combination of frequency and power, act on the balance between the internal positive charges of the virus and the negative charges present in the capsid or outer shell, giving rise to a 'resonance' phenomenon that destroys the external envelope of the virus and effectively inhibits its power to spread and to infect.
The key intuitive moment came during the pandemic period and required two years of studies and in-depth analysis, starting from a research carried out by Taiwanese scientists published in the Nature Scientific Report. The first results came from testing different frequencies of electromagnetic waves on Covid and later, on other pathogens. One of the most interesting features of this new technology is the possibility of having a targeted action, allowing it to be calibrated on specific pathogens changing the resonance frequence.
Its effectiveness has been validated against Covid, including recent variants, RSV and seasonal flu (in this case the effectiveness exceeds 95%), Avian Flu and Swine Flu. e4life has an important roadmap of research focused on constantly evolving and adapting the devices to an ever-increasing number of viruses and, in the near future, also bacteria.
There are currently three products available using this technology, two for humans and one for animals. e4life personal is the portable, lightweight, compact version (100 grams x 8.5 cm) which is SAR certified. It is comfortable and safe to wear and is able to inactivate viruses by generating a 'bubble' with a diameter of about three metres. Then there is e4life ambient which is the 'fixed' version to be installed either on ceiling or walls with a range of action covering about 50 square metres.
Lastly there is e4life FARM, the device dedicated to livestock farms and designed to combat animal viral diseases (actually Avian Flu and Swine Flu) which represent a threat to chicken, turkey and pigs.
'This technology marks a breakthrough for applications in high-risk environments, both human and animal, such as farms, where controlling airborne virus transmission is essential, to minimize contagion among the animals themselves and also to reduce the risk of spillover - declares e4life CEO Vincenzo Pompa -. The focus and efficacy of our devices perfectly represent the meaning of what we are doing: it is the starting point of our commitment and it is closely linked to the concept of "One Health", an approach that recognizes and promotes the fundamental interconnection between human, animal and environmental health. Our goal is to revolutionize the biodefense sector through our solutions which allow each individual to enjoy a natural social life, interacting in safe spaces with no concerns or worries'.
Further confirmation of the value and importance of the results achieved by e4life are the numerous examples of recognition it has now received. In actual fact this technology has been subjected to scientific tests and has been validated by the Celio Military Hospital, the independent ViroStatics Institute and two studies published in the Viruses and the European Society of Medicine journals (Source: Esmed.org).
The technology has also been the subject of a test campaign carried out at Milan University's Department of Biomedical and Clinical Sciences. The results confirm those already obtained from previous test campaigns, i.e. a replicable efficacy of close to 90%. The Bio-Medico Campus at the University of Rome has instead collaborated in working on the control and efficacy of this technology.
Furthermore, the JRC–HERA technological prospective study by the European Commission Joint Research Centre includes this technology among those which are currently available that can guarantee an increase in air quality in indoor environments.
The already considerable number of validations has been expanded to include certification obtained from the University of Genoa, which has tested the technology's efficacy of over 90% on influenza and Covid viruses. A final further 'seal of guarantee' comes from an article in the scientific journal Nature Scientific Reports, which describes a study demonstrating the effectiveness of electromagnetic waves in inactivating the avian flu virus.
Moreover, the inactivation systems for respiratory viruses using electromagnetic waves have been included in the UNI/PdR 173-1 Reference Practices for Indoor Sanitization, a document drafted by UNI — the Italian Standardization Body — in collaboration with the National Institute of Health (Istituto Superiore di Sanità). This document sets out the requirements for managing indoor sanitization and the solutions that, even though they are not classified as medical devices, may be used for that purpose.
The e4life devices are currently certified to be marketed in Europe, Australia, Japan, Singapore, Saudi Arabia, UAE, Morocco and Egypt.